JGEP:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF GBP Hedged Acc (GBX)

ETF | Others |

Last Closing

USD 3659.75

Change

0.00 (0.00)%

Market Cap

USD 0.21B

Volume

3.65K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.07 (+0.92%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.10 (-0.54%)

USD 557.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.03 (-0.19%)

USD 496.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.60 (+0.84%)

USD 266.08B
0QZO:LSE 0QZO

+0.65 (+0.71%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+2.09 (+1.27%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.13 (-0.41%)

USD 200.01B
0R24:LSE Intel Corp.

+1.67 (+8.20%)

USD 196.14B

ETFs Containing JGEP:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.24% 88% B+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.24% 87% B+ 80% B-
Trailing 12 Months  
Capital Gain 23.68% 84% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.68% 84% B 79% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.88% 70% C- 72% C
Dividend Return 10.88% 69% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.83% 61% D- 77% C+
Risk Adjusted Return 100.39% 94% A 97% N/A
Market Capitalization 0.21B 61% D- 35% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike